©The Author(s) 2021.
World J Clin Cases. Dec 16, 2021; 9(35): 10884-10898
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10884
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10884
Table 1 Clinical characteristics of the pancreatic cancer patients used in this study
| Variables | TCGA data |
| Number of patients | 176 |
| Age (median, range) | 65 (35-88) |
| Sex (%) | |
| Female | 80 (45.5%) |
| Male | 96 (54.5%) |
| Grade (%) | |
| Grade 1 | 30 (17%) |
| Grade 2 | 94 (53.4%) |
| Grade 3 | 48 (27.3%) |
| Grade 4 | 2 (1.1%) |
| Unknown | 2 (1.1%) |
| Stage (%) | |
| I | 21 (11.9%) |
| II | 145 (82.4%) |
| III | 3 (1.7%) |
| IV | 4 (2.3%) |
| Unknown | 3 (1.7%) |
| Survival status | |
| OS days (median) | 464.5 |
| Censored (%) | 92 (52.3%) |
- Citation: Xu H, Sun J, Zhou L, Du QC, Zhu HY, Chen Y, Wang XY. Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer. World J Clin Cases 2021; 9(35): 10884-10898
- URL: https://www.wjgnet.com/2307-8960/full/v9/i35/10884.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i35.10884